Cancer Care Ontario | Cancer Care Ontario

First-line treatment of adult patients diagnosed with FLT3-mutated acute myeloid leukemia, in combination with specific standard induction followed by consolidation chemotherapy, according to clinical criteria

Show More Show more tags

, Show Less Show fewer tags

Drugs Used:

cytarabine,

midostaurin

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Oct 2018

Guidelines and Advice

Guidance for Kyphoplasty and Vertebroplasty for Cancer Patients in Ontario: Recommendations Report 2017

Status: Current
Version: 2

Oct 2018

Cancer facts

Over 1,300 annual cancer cases caused by HPV could be prevented in Ontario

Oct 2018

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2018

Status: Current
ID: pet 2018-1
Version: n/a

Oct 2018

Guidelines and Advice

Cancer Screening for Persons at Risk for or Affected with Lynch Syndrome Evidence Summary

Status: In-Review
ID: ES 15-16

Oct 2018

Use of Continuous Infusion Pumps During Radiation Treatment: Recommendation Report (March 2012)

High Smoking and Obesity Rates Causing Increased Cancer Risk in Ontario Métis

Kidney Cancer Incidence Rates Still Rising in Ontario

Cancer Care Ontario’s Position Statement on Guidelines for Breast Cancer Well Follow-Up Care

A Pan-Canadian Practice Guideline: Prevention, Screening, Assessment and Treatment of Sleep Disturbances in Adults with Cancer

CYTA(HD)+MIDO

Guidance for Kyphoplasty and Vertebroplasty for Cancer Patients in Ontario: Recommendations Report 2017

Over 1,300 annual cancer cases caused by HPV could be prevented in Ontario

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines January to June 2018

Cancer Screening for Persons at Risk for or Affected with Lynch Syndrome Evidence Summary

Pages